GlassScriptPhysician profile
Harry D Jameson
NPI 1194710673
$1,027.42
in general payments reported to CMS, 2019-2025
23 companies · $232 in 2025
The $232 reported for 2025 was more than what 78% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $466 · 2020: $112 · 2021: $21.41 · 2022: $19.02 · 2023: $50.85 · 2024: $126 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $409.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $140.07 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $111.08 | 2019-2025 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Amgen INC. | $103.81 | 2019 | |
| Tris Pharma INC | $82.73 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $77.76 | 2019-2024 | |
| Pfizer INC. | $63.38 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $55.32 | 2025 | Qelbree |
| Collegium Pharmaceutical, INC. | $47.70 | 2025 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $41.08 | 2025 | |
| Glaxosmithkline, LLC. | $40.77 | 2019 | |
| Cranial Technologies, INC | $33.17 | 2023 | Doc Band |
| Dermira, INC. | $31.90 | 2019 | |
| Cardiovascular Systems INC. | $29.17 | 2019 | |
| Abbvie INC. | $21.79 | 2020 | |
| Lnhc, INC | $18.92 | 2025 | Zelsuvmi |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $18.49 | 2025 | Zoryve |
| Seqirus USA INC | $17.88 | 2020 | |
| Jazz Pharmaceuticals INC. | $17.73 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.28 | 2019 | |
| Hologic Sales and Service, LLC | $15.97 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $15.69 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.33 | 2020 | |
| Corium, LLC | $11.40 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Jameson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.